CoChat

Depletion of B cell‐activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease

Open access

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Abstract

Obesity-induced adipose-tissue dysfunction is a critical contributor to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). B cell-activating factor (BAFF) is an adipokine related to impaired insulin sensitivity, and the serum BAFF concentration is associated with NAFLD severity. In this study, we aimed to determine the direct in vivo role of BAFF in the development of insulin resistance, adipocyte dysfunction, and hepatic steatosis using BAFF −/− mice fed a high-fat diet (HFD). HFD-fed BAFF −/− mice exhibited significantly improved insulin sensitivity despite their increased weight gain and adiposity relative to HFD-fed wild-type mice. Moreover, inflammation, especially the accumulation of CD11c + adipose-tissue macrophages, and fibrosis of epididymal adipose tissue were reduced, contributing to healthy adipose-tissue expansion in obese BAFF −/− mice. In line with metabolically healthy obesity, hepatic steatosis also decreased, and we observed attenuated de novo lipogenesis in both the livers and hepatocytes of BAFF −/− mice. Our data revealed that BAFF serves as a potential stimulator of unhealthy adipose-tissue expansion by triggering inflammation and fibrosis and ultimately leading to enhanced insulin resistance and NAFLD. Therefore, these results suggest that BAFF is a promising target for diabetes and NAFLD treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-37403-y

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Lipid distribution in adipose tissue and liver is altered in BAFF−/− mice fed an HFD. (A) Changes in body weight of BAFF−/− and WT mice fed an ND or HFD (n = 25–55/group). (B) Organ weight [(organ weight/body weight) × 100%] in BAFF−/− and WT mice fed an ND (n = 6/group) or HFD (n = 7/group) for 24 weeks. For all bar plots shown, data are expressed as the mean ± SD, and significance was determined by two-tailed Student’s t test (A) and Mann–Whitney U test (B). ♯♯♯P < 0.001 compared to WT-ND mice. *P < 0.05, **P < 0.01, and ***P < 0.001 compared to WT-HFD mice. BAFF, B cell-activating factor; WT, wild-type; ND, normal diet; HFD, high-fat diet; SAT, subcutaneous adipose tissue; EAT, epididymal adipose tissue; RpAT, retroperitoneal adipose tissue; VAT, visceral adipose tissue; BAT, brown adipose tissue.
Figure 1 Lipid distribution in adipose tissue and liver is altered in BAFF−/− mice fed an HFD. (A) Changes in body weight of BAFF−/− and WT mice fed an ND or HFD (n = 25–55/group). (B) Organ weight [(organ weight/body weight) × 100%] in BAFF−/− and WT mice fed an ND (n = 6/group) or HFD (n = 7/group) for 24 weeks. For all bar plots shown, data are expressed as the mean ± SD, and significance was determined by two-tailed Student’s t test (A) and Mann–Whitney U test (B). ♯♯♯P < 0.001 compared to WT-ND mice. *P < 0.05, **P < 0.01, and ***P < 0.001 compared to WT-HFD mice. BAFF, B cell-activating factor; WT, wild-type; ND, normal diet; HFD, high-fat diet; SAT, subcutaneous adipose tissue; EAT, epididymal adipose tissue; RpAT, retroperitoneal adipose tissue; VAT, visceral adipose tissue; BAT, brown adipose tissue.CC BY · PubMed Central
Figure 2 BAFF−/− mice are protected against glucose intolerance and insulin resistance. (A) Fasting blood glucose, plasma insulin, and HOMA-IR values in HFD-fed BAFF−/− and WT mice over the course of 12 weeks (n = 6/group). (B) Glucose- and (C) insulin-tolerance tests (left) and corresponding area under the curve (AUC) values during the tests (right) (n = 7–14/group). For all bar plots, data are expressed as the mean ± SD, and significance was determined by the Mann–Whitney U test. *P < 0.05, **P < 0.01, and ***P < 0.001. BAFF, B cell-activating factor; WT, wild-type; ND, normal diet; HFD, high-fat diet; HOMA-IR, calculated homeostasis model assessment of insulin resistance.
Figure 2 BAFF−/− mice are protected against glucose intolerance and insulin resistance. (A) Fasting blood glucose, plasma insulin, and HOMA-IR values in HFD-fed BAFF−/− and WT mice over the course of 12 weeks (n = 6/group). (B) Glucose- and (C) insulin-tolerance tests (left) and corresponding area under the curve (AUC) values during the tests (right) (n = 7–14/group). For all bar plots, data are expressed as the mean ± SD, and significance was determined by the Mann–Whitney U test. *P < 0.05, **P < 0.01, and ***P < 0.001. BAFF, B cell-activating factor; WT, wild-type; ND, normal diet; HFD, high-fat diet; HOMA-IR, calculated homeostasis model assessment of insulin resistance.CC BY · PubMed Central
Figure 3 Adipose tissue inflammation is alleviated in BAFF−/− mice. (A) Representative H&E staining of EAT (left). The arrows point to the CLSs formed by macrophage aggregation. Quantitative measurement of CLSs (right) (scale bar, 200 μm; images from six different fields; n = 5/group). (B,D) Relative mRNA levels of the indicated genes in the EAT (n = 12/group). (C) Representative flow cytometry plots showing frequencies of CD11c+ F4/80+ macrophages among stromal cells isolated from EATs from HFD-fed BAFF−/− and WT mice (left). Quantification of Cd11c+ F4/80+ cells isolated from EAT (right) (n = 9–12/group). (E) Serum resistin concentrations (n = 14, 15/group). For all bar plots, data are expressed as the means ± SEM. *P < 0.05 and ***P < 0.001 (Mann–Whitney U test). BAFF, B cell-activating factor; WT, wild-type; H&E, haematoxylin and eosin; CLS, crown-like structure; HFD, high-fat diet; EAT, epididymal adipose tissue.
Figure 3 Adipose tissue inflammation is alleviated in BAFF−/− mice. (A) Representative H&E staining of EAT (left). The arrows point to the CLSs formed by macrophage aggregation. Quantitative measurement of CLSs (right) (scale bar, 200 μm; images from six different fields; n = 5/group). (B,D) Relative mRNA levels of the indicated genes in the EAT (n = 12/group). (C) Representative flow cytometry plots showing frequencies of CD11c+ F4/80+ macrophages among stromal cells isolated from EATs from HFD-fed BAFF−/− and WT mice (left). Quantification of Cd11c+ F4/80+ cells isolated from EAT (right) (n = 9–12/group). (E) Serum resistin concentrations (n = 14, 15/group). For all bar plots, data are expressed as the means ± SEM. *P < 0.05 and ***P < 0.001 (Mann–Whitney U test). BAFF, B cell-activating factor; WT, wild-type; H&E, haematoxylin and eosin; CLS, crown-like structure; HFD, high-fat diet; EAT, epididymal adipose tissue.CC BY · PubMed Central
Figure 4 Interstitial fibrosis in white adipose tissue is reduced in BAFF−/− mice. (A) The median adipocyte size (left) and the distribution of adipocyte size (right) in EAT from HFD-fed BAFF−/− and WT mice. Representative (B) Sirius red staining and (C) quantification of Sirius red-positive areas of EAT (scale bar, 100 μm; images from 10 different fields; n = 6/group). (D) Total collagen contents in EAT (n = 9–13/group). (E) Expression of genes related to fibrosis in EAT (n = 14–15/group). For all bar plots, data are expressed as the mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 (Mann-Whitney U test). BAFF, B cell-activating factor; HFD, high-fat diet; WT, wild-type; EAT, epididymal adipose tissue; TGF, transforming growth factor; SMA, smooth muscle actin; Col, Collagen.
Figure 4 Interstitial fibrosis in white adipose tissue is reduced in BAFF−/− mice. (A) The median adipocyte size (left) and the distribution of adipocyte size (right) in EAT from HFD-fed BAFF−/− and WT mice. Representative (B) Sirius red staining and (C) quantification of Sirius red-positive areas of EAT (scale bar, 100 μm; images from 10 different fields; n = 6/group). (D) Total collagen contents in EAT (n = 9–13/group). (E) Expression of genes related to fibrosis in EAT (n = 14–15/group). For all bar plots, data are expressed as the mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 (Mann-Whitney U test). BAFF, B cell-activating factor; HFD, high-fat diet; WT, wild-type; EAT, epididymal adipose tissue; TGF, transforming growth factor; SMA, smooth muscle actin; Col, Collagen.CC BY · PubMed Central
Figure 5 Hepatic steatosis is ameliorated in HFD-fed BAFF−/− mice. (A) Representative H&E staining of livers from mice after 24 weeks of ND or HFD consumption (scale bar, 500 μm). (B) Representative OsO4 staining (left) and quantification of the OsO4-positive areas (right) of livers (scale bar, 500 μm; images from eight different fields; n = 8/group). (C) Hepatic TG and (D) total cholesterol levels (n = 5/group). For all bar plots, data are expressed as the mean ± SEM, and significance was determined by the Mann–Whitney U test. *P < 0.05 and ***P < 0.001. BAFF, B cell-activating factor; WT, wild-type; ND, normal diet; HFD, high-fat diet; TG, triglyceride.
Figure 5 Hepatic steatosis is ameliorated in HFD-fed BAFF−/− mice. (A) Representative H&E staining of livers from mice after 24 weeks of ND or HFD consumption (scale bar, 500 μm). (B) Representative OsO4 staining (left) and quantification of the OsO4-positive areas (right) of livers (scale bar, 500 μm; images from eight different fields; n = 8/group). (C) Hepatic TG and (D) total cholesterol levels (n = 5/group). For all bar plots, data are expressed as the mean ± SEM, and significance was determined by the Mann–Whitney U test. *P < 0.05 and ***P < 0.001. BAFF, B cell-activating factor; WT, wild-type; ND, normal diet; HFD, high-fat diet; TG, triglyceride.CC BY · PubMed Central
Figure 6 The expression of genes related to steatosis is downregulated in the livers of BAFF−/− mice. (A,C,D) The expression of genes related to lipogenesis (A), inflammation (C), and fibrosis (D) in mouse livers after 24 weeks of HFD consumption (n = 9–14/group). (B) The expression of proteins related to lipogenesis (n = 4/group). Original gel documents of western blot were shown in Supplementary Fig. S4. Protein levels were normalized to those of β-actin, and those of WT mice were set at 1. For all bar plots, data are expressed as the mean ± SEM, and significance was determined by Mann–Whitney U test. *P < 0.05 and ***P < 0.001. BAFF, B cell-activating factor; WT, wild-type; HFD, high-fat diet; FAS, fatty acid synthase; SREBP1, sterol regulatory element-binding protein; ACC, acetyl-CoA carboxylase; SCD, stearoyl-CoA desaturase; ACS, acetyl-CoA synthetase; MTP, microsomal triglyceride transfer protein; TNF, tumour necrosis factor.
Figure 6 The expression of genes related to steatosis is downregulated in the livers of BAFF−/− mice. (A,C,D) The expression of genes related to lipogenesis (A), inflammation (C), and fibrosis (D) in mouse livers after 24 weeks of HFD consumption (n = 9–14/group). (B) The expression of proteins related to lipogenesis (n = 4/group). Original gel documents of western blot were shown in Supplementary Fig. S4. Protein levels were normalized to those of β-actin, and those of WT mice were set at 1. For all bar plots, data are expressed as the mean ± SEM, and significance was determined by Mann–Whitney U test. *P < 0.05 and ***P < 0.001. BAFF, B cell-activating factor; WT, wild-type; HFD, high-fat diet; FAS, fatty acid synthase; SREBP1, sterol regulatory element-binding protein; ACC, acetyl-CoA carboxylase; SCD, stearoyl-CoA desaturase; ACS, acetyl-CoA synthetase; MTP, microsomal triglyceride transfer protein; TNF, tumour necrosis factor.CC BY · PubMed Central
Figure 7 Hepatocyte fat deposition is reduced in BAFF−/− mice. (A) The expression of genes related to lipogenesis in primary hepatocytes from HFD-fed BAFF−/− and WT mice. (B) Hepatocyte fat deposition. Representative Sudan III staining of primary hepatocytes from BAFF−/− and WT mice exposed to BSA or PA (left). Quantification of TG in primary hepatocytes exposed to PA (right) (n = 8/group). For all bar plots, data are expressed as the mean ± SEM. ***P < 0.001 (Mann–Whitney U test). BAFF, B cell-activating factor; WT, wild-type; FAS, Fatty acid synthase; SREBP1, sterol regulatory element-binding protein; ACC, acetyl-CoA carboxylase; SCD, stearoyl-CoA desaturase; MTP, microsomal triglyceride transfer protein; BSA, bovine serum albumin; PA, palmitate, TG; triglyceride.
Figure 7 Hepatocyte fat deposition is reduced in BAFF−/− mice. (A) The expression of genes related to lipogenesis in primary hepatocytes from HFD-fed BAFF−/− and WT mice. (B) Hepatocyte fat deposition. Representative Sudan III staining of primary hepatocytes from BAFF−/− and WT mice exposed to BSA or PA (left). Quantification of TG in primary hepatocytes exposed to PA (right) (n = 8/group). For all bar plots, data are expressed as the mean ± SEM. ***P < 0.001 (Mann–Whitney U test). BAFF, B cell-activating factor; WT, wild-type; FAS, Fatty acid synthase; SREBP1, sterol regulatory element-binding protein; ACC, acetyl-CoA carboxylase; SCD, stearoyl-CoA desaturase; MTP, microsomal triglyceride transfer protein; BSA, bovine serum albumin; PA, palmitate, TG; triglyceride.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 37

Metadata

Authors
Nakamura, Y., Abe, M., Kawasaki, K., Miyake, T., Watanabe, T., Yoshida, O., Hirooka, M., Matsuura, B., & Hiasa, Y.
Affiliations
Ehime University (JP)
Corresponding author
Abe, Masanori
Venue
Scientific Reports
Published
2019-01-30
Volume
9
Issue
1
Pages
977-977
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2912238297
Cited by
34
References
35
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 3
FWCI
3.24
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
MEXT | Japan Society for the Promotion of Science (15K09007, 18K07911)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
B-cell activating factor, BAFF, non-alcoholic fatty liver disease, hepatic steatosis, insulin resistance, adipose tissue dysfunction, adipose tissue macrophages, adipose tissue inflammation, adipose tissue fibrosis, de novo lipogenesis, high-fat diet, metabolically healthy obesity, adipokines
MeSH terms
Adipose Tissue, Animals, Disease Models, Animal, Fibrosis, Inflammation, Insulin Resistance, Lipids, Liver, Male, Mice, Inbred C57BL, Down-Regulation, Glucose Intolerance, Hepatocytes, Adiposity, B-Cell Activating Factor, Diet, High-Fat, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Depletion of B cell‐activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease. https://app.cochat.ai/papers/10.1038/s41598-018-37403-y
The paper
Nakamura, Y., Abe, M., Kawasaki, K., Miyake, T., Watanabe, T., Yoshida, O., Hirooka, M., Matsuura, B., & Hiasa, Y. (2019). Depletion of B cell‐activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease. Scientific Reports. https://doi.org/10.1038/s41598-018-37403-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.